Turkish oncology centers offer integrated melanoma treatments including wide local excision, Mohs microsurgery, and immunotherapy with drugs like Keytruda. JCI-accredited facilities follow international NCCN protocols. Specialized options such as Actinium-225 therapy and Natural Killer cell therapy are also available for advanced cases in Istanbul.
- Surgical excision: Surgeons perform wide local excision or precise Mohs microsurgery for lesions.
- Advanced immunotherapy: Clinics provide checkpoint inhibitors like Keytruda to boost the immune system.
- Nuclear medicine: Centers like Anadolu provide Actinium-225 therapy for specific metastatic cancer types.
- Precision diagnostics: Specialists use BRAF gene mutation testing to guide targeted therapy selection.
Bookimed Expert Insight: Anadolu Medical Center stands out because it is the only Turkish facility affiliated with Johns Hopkins Medicine. It integrates OECI-accredited cancer care with high patient volumes of 65,000 annually. This combination of American medical standards and high-frequency surgical experience typically results in more refined diagnostic histopathology revisions.
Patient Consensus: Patients emphasize the importance of having personal coordinators who handle the complex logistics of multi-day immunotherapy cycles. Many note that the multidisciplinary team approach helps them feel more confident during recovery.